PKP2 and arrhythmogenic right ventricular cardiomyopathy: Studies in PKP2 Hom mice most importantly show broad applicability of therapeutic approaches to restore PKP2 RNA and protein levels (through PKP2 gene therapy) for PKP2 ARVC populations, including splice site mutations.